Saturday, August 2, 2025 8/2/2025

HIV DART:FRONTIERS IN DRUG DEVELOPMENT FOR ARV THERAPIES

Award Number: R13AI065203
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/09/2004
PERIOD OF PERFORMANCE END DATE: 11/30/2009

Group Awards By:

View Award Description

HIV DART:FRONTIERS IN DRUG DEVELOPMENT FOR ARV THERAPIES - HIV DART: Frontiers in Drug Development for Antiretroviral Therapies is an independent biennial conference attracting at least 300 attendees. HIV DART is open to anyone interested in HIV therapeutics, with content developed to interest physicians, clinicians, scientists and clinical researchers in infectious diseases. SPECIFIC AIMS: The aim of HIV DART is to assemble clinicians, researchers and basic scientists together to advance knowledge of the ongoing drug development processes in antiretroviral research. HIV DART uniquely blends the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community an increased understanding of the current and future challenges in therapeutics for HIV infection. OBJECTIVES: (1) Understand the role of viral targets in the drug development and discovery process (2) Identify novel therapeutic agents and viral targets (3) Understand the consequences of co-infection with hepatitis on the management of patients with HIV infection. DESIGN: The scientific content of HIV DART covers the following areas: (1) Drug Discovery and Development: Viral Targets (2) Drug Design: Biochemistry & Mechanism (3) Structural Biology & New Drug Development (4) Immunotherapy & Vaccines for HIV Infection (5) First-line Antiretroviral/Salvage Therapy (6) Complications of Antiretroviral Therapy: Basic to Clinical (7) HIV/Hepatitis and Other Co-infections. METHODS: HIV DART comprises four days of scientific presentations, delivered in both oral and poster presentations formats. Northwestern University, Feinberg School of Medicine Office of Continuing Medical Education designates HIV DART for a maximum 25 category 1 credits toward the AMA Physician's Recognition Award. HIV DART provides a relaxed and scientifically stimulating atmosphere for both PhDs and MDs to network and learn together. Support is requested to help defray the publications costs of the abstract book and for equipment used to facilitate delivery and display of the oral and poster presentations.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2009 ( Subtotal = $14,850 )
2009	2009	INFORMED HORIZONS LLC	1631 PHOENIX BLVD, ste 4	COLLEGE PARK	GA	30349	FULTON	USA	Allergy and Infectious Diseases Research	000	5	11/19/2008	NON-COMPETING CONTINUATION	$14,850
														Subtotal = $14,850

Issue Date FY: 2008 ( Subtotal = $1 )
2008	2008	INFORMED HORIZONS LLC	1631 PHOENIX BLVD, ste 4	COLLEGE PARK	GA	30349	FULTON	USA	Allergy and Infectious Diseases Research	000	4	12/5/2007	NON-COMPETING CONTINUATION	$1
														Subtotal = $1

Issue Date FY: 2007 ( Subtotal = $16,500 )
2007	2007	INFORMED HORIZONS LLC	1631 PHOENIX BLVD, ste 4	COLLEGE PARK	GA	30349	FULTON	USA	Allergy and Infectious Diseases Research	000	3	11/28/2006	NON-COMPETING CONTINUATION	$16,500
														Subtotal = $16,500

Issue Date FY: 2006 ( Subtotal = $1 )
2006	2006	INFORMED HORIZONS LLC	1631 PHOENIX BLVD, ste 4	COLLEGE PARK	GA	30349	FULTON	USA	Allergy and Infectious Diseases Research	000	2	12/8/2005	NON-COMPETING CONTINUATION	$1
														Subtotal = $1

Issue Date FY: 2005 ( Subtotal = $16,500 )
2005	2005	INFORMED HORIZONS LLC	1631 PHOENIX BLVD, ste 4	COLLEGE PARK	GA	30349	FULTON	USA	Microbiology and Infectious Diseases Research	000	1	12/9/2004	NEW	$16,500
														Subtotal = $16,500

Grand Total All Awards = $47,852

Top

All Categories

About

Search

Reports

Data Submission

Award Information

HIV DART:FRONTIERS IN DRUG DEVELOPMENT FOR ARV THERAPIES

Award Number: R13AI065203

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/09/2004

PERIOD OF PERFORMANCE END DATE: 11/30/2009

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer